Early Phase II clinical study of AK150 for the treatment of knee osteoarthritis
Phase 2
- Conditions
- Knee Osteoarthritis
- Registration Number
- JPRN-jRCT2080221101
- Lead Sponsor
- ASAHI KASEI PHARMA CORPORATIO
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
(1)Ambulatory outpatients who do not need a cane or other orthopedic device to enable or assist in motility.
(2)Knee pain has experienced
(3)Patients should have a 2 - 3 on the Kellgren-Lawrence (K-L) grading scale by X-Ray.
Exclusion Criteria
(1) Having undergone some sort of surgical procedure or some other kind of invasive procedure in the evaluated knee.
(2) Secondary knee osteoarthritis in the evaluated knee.
(3) Intra-articular administration of hyaluronic acid to the evaluated knee within 3 months prior to the start of administration.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method